Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ABL Bio Inc.- GenScript Biotech Corp Bispecific Antibody Strategic Partnership Agreement Ceremony 2019-11-18 22:00
RhoVac Reports Interim Results on Immunological Response with RV001 2019-11-18 17:13
Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People 2019-11-17 12:00
Viva Biotech Partnership Summit Successfully Launched in Shanghai 2019-11-15 14:16
World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers 2019-11-14 11:07
Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner 2019-11-14 08:00
China Biologic Reports Financial Results for the Third Quarter of 2019 2019-11-14 05:43
Merck Licenses CRISPR Gene-Editing Technology to Evotec 2019-11-12 21:00
Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device Powered by Neuroscience to Optimize Sleep Health and Address the Global Sleep Crisis, Without Medication 2019-11-12 20:18
AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint 2019-11-12 20:00
ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders 2019-11-11 21:45
Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director 2019-11-11 19:30
Akeso, Inc. Completes Series-D Private Financing for US$150 Million 2019-11-09 00:43
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company 2019-11-08 21:24
Ivantis Announces 3 Year Results of Australian SPECTRUM Registry for Hydrus Microstent 2019-11-08 03:00
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 21:02
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million 2019-11-07 19:04
First Asia-Pacific hospital treats patients with RayStation and Radixact 2019-11-07 09:00
1 305 306 307 308 309 451